Cardiovascular Systems (CSII) Tops Q3 EPS by 3c

Cardiovascular Systems (NASDAQ: CSII) reported Q3 EPS of ($0.25), $0.03 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $56.2 million versus the consensus estimate of $57.38 million.

GUIDANCE:

Cardiovascular Systems sees FY2022 revenue of $235-240 million, versus the consensus of $237.89 million.

For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.

You May Also Be Interested In

• Shotspotter (SSTI) Misses Q1 EPS by 15c, provides guidance
• Seadrill Ltd. (SDRL) Tops Q1 EPS by 15c; reaffirms FY guidance
• Boston Omaha Corporation (BOC) Misses Q1 EPS by 1c